GeneBio Systems
FUNDC2 Polyclonal Antibody
FUNDC2 Polyclonal Antibody
SKU:E-AB-18928
Couldn't load pickup availability
Size: 200μL
Storage: Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping: The product is shipped with ice pack,upon receipt,store it immediately at the temperature recommended.
Exp date: 12 months
Category ID_II: Primary Antibodies
Category ID_III: Polyclonal Antibodies
Abbreviation: FUNDC2
Target Synonym: Cervical cancer oncogene 3;Cervical cancer proto oncogene 3 protein;DC44;FLJ33773;FUN14 domain containing 2;FUN14 domain containing protein 2;FUNDC 2;HCBP 6;HCBP6;HCC 3;HCC3;Hepatitis C virus core binding protein 6;MGC131676;MGC2495;OTTHUMP00000015441;OTTHUMP00000061459;PD03104
Research Areas: Epigenetics and Nuclear Signaling;Metabolism;Microbiology;Signal transduction
Conjugation: Unconjugated
Host: Rabbit
Species reactivity: Human
Application: IHC
Isotype: IgG
Clonality: Polyclonal
Clone NO.:
UNIProt ID: Q9BWH2
Accession:
Background: FUNDC2 (FUN14 domain-containing protein 2), also known as HCC-3 (cervical cancer proto-oncogene 3 protein), HCBP6 (hepatitis C virus core-binding protein 6) or DC44, is a 189 amino acid protein belonging to the FUN14 family. The gene encoding FUNDC2 maps to human chromosome Xq28. The X and Y chromosomes are the human sex chromosomes. Chromosome X consists of about 153 million base pairs and nearly 1,000 genes. The combination of an X and Y chromosome lead to normal male development while two copies of X lead to normal female development. More than one copy of the X chromosome with a Y chromosome causes Klinefelter's syndrome. A single copy of X alone leads to Turner's syndrome. More than 2 copies of the X chromosome, in the absence of a Y chromosome, is known as Triple X syndrome. Color blindness, hemophilia, and Duchenne muscular dystrophy are well known X chromosome-linked conditions which affect males more frequently as males carry a single X chromosome.
Concentration: 0.72 mg/mL
Immunogen: Fusion protein of human FUNDC2
Buffer: PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Purification method: Antigen affinity purification
Dilution: IHC 1:50-1:300
Calculated MW:
ObservedMW:
